Global Tuberculosis Vaccine Drug Supply, Demand and Key Producers, 2023-2029
The global Tuberculosis Vaccine Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Tuberculosis Vaccine Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tuberculosis Vaccine Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tuberculosis Vaccine Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tuberculosis Vaccine Drug total production and demand, 2018-2029, (K Units)
Global Tuberculosis Vaccine Drug total production value, 2018-2029, (USD Million)
Global Tuberculosis Vaccine Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tuberculosis Vaccine Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Tuberculosis Vaccine Drug domestic production, consumption, key domestic manufacturers and share
Global Tuberculosis Vaccine Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Tuberculosis Vaccine Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tuberculosis Vaccine Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Tuberculosis Vaccine Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tuberculosis Vaccine Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tuberculosis Vaccine Drug Market, By Region:
1. How big is the global Tuberculosis Vaccine Drug market?
2. What is the demand of the global Tuberculosis Vaccine Drug market?
3. What is the year over year growth of the global Tuberculosis Vaccine Drug market?
4. What is the production and production value of the global Tuberculosis Vaccine Drug market?
5. Who are the key producers in the global Tuberculosis Vaccine Drug market?
6. What are the growth factors driving the market demand?
This report studies the global Tuberculosis Vaccine Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tuberculosis Vaccine Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tuberculosis Vaccine Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tuberculosis Vaccine Drug total production and demand, 2018-2029, (K Units)
Global Tuberculosis Vaccine Drug total production value, 2018-2029, (USD Million)
Global Tuberculosis Vaccine Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tuberculosis Vaccine Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Tuberculosis Vaccine Drug domestic production, consumption, key domestic manufacturers and share
Global Tuberculosis Vaccine Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Tuberculosis Vaccine Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tuberculosis Vaccine Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Tuberculosis Vaccine Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tuberculosis Vaccine Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tuberculosis Vaccine Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Immune Vaccine
- Therapy Vaccine
- Self-Procurement
- UNICEF
- Other
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Ataulpho de Paiva
- IVAC
- Queen Saovabha Mem. Inst
- Microgen
1. How big is the global Tuberculosis Vaccine Drug market?
2. What is the demand of the global Tuberculosis Vaccine Drug market?
3. What is the year over year growth of the global Tuberculosis Vaccine Drug market?
4. What is the production and production value of the global Tuberculosis Vaccine Drug market?
5. Who are the key producers in the global Tuberculosis Vaccine Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Tuberculosis Vaccine Drug Introduction
1.2 World Tuberculosis Vaccine Drug Supply & Forecast
1.2.1 World Tuberculosis Vaccine Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Tuberculosis Vaccine Drug Production (2018-2029)
1.2.3 World Tuberculosis Vaccine Drug Pricing Trends (2018-2029)
1.3 World Tuberculosis Vaccine Drug Production by Region (Based on Production Site)
1.3.1 World Tuberculosis Vaccine Drug Production Value by Region (2018-2029)
1.3.2 World Tuberculosis Vaccine Drug Production by Region (2018-2029)
1.3.3 World Tuberculosis Vaccine Drug Average Price by Region (2018-2029)
1.3.4 North America Tuberculosis Vaccine Drug Production (2018-2029)
1.3.5 Europe Tuberculosis Vaccine Drug Production (2018-2029)
1.3.6 China Tuberculosis Vaccine Drug Production (2018-2029)
1.3.7 Japan Tuberculosis Vaccine Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tuberculosis Vaccine Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tuberculosis Vaccine Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Tuberculosis Vaccine Drug Demand (2018-2029)
2.2 World Tuberculosis Vaccine Drug Consumption by Region
2.2.1 World Tuberculosis Vaccine Drug Consumption by Region (2018-2023)
2.2.2 World Tuberculosis Vaccine Drug Consumption Forecast by Region (2024-2029)
2.3 United States Tuberculosis Vaccine Drug Consumption (2018-2029)
2.4 China Tuberculosis Vaccine Drug Consumption (2018-2029)
2.5 Europe Tuberculosis Vaccine Drug Consumption (2018-2029)
2.6 Japan Tuberculosis Vaccine Drug Consumption (2018-2029)
2.7 South Korea Tuberculosis Vaccine Drug Consumption (2018-2029)
2.8 ASEAN Tuberculosis Vaccine Drug Consumption (2018-2029)
2.9 India Tuberculosis Vaccine Drug Consumption (2018-2029)
3 WORLD TUBERCULOSIS VACCINE DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Tuberculosis Vaccine Drug Production Value by Manufacturer (2018-2023)
3.2 World Tuberculosis Vaccine Drug Production by Manufacturer (2018-2023)
3.3 World Tuberculosis Vaccine Drug Average Price by Manufacturer (2018-2023)
3.4 Tuberculosis Vaccine Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Tuberculosis Vaccine Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Tuberculosis Vaccine Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Tuberculosis Vaccine Drug in 2022
3.6 Tuberculosis Vaccine Drug Market: Overall Company Footprint Analysis
3.6.1 Tuberculosis Vaccine Drug Market: Region Footprint
3.6.2 Tuberculosis Vaccine Drug Market: Company Product Type Footprint
3.6.3 Tuberculosis Vaccine Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Tuberculosis Vaccine Drug Production Value Comparison
4.1.1 United States VS China: Tuberculosis Vaccine Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Tuberculosis Vaccine Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Tuberculosis Vaccine Drug Production Comparison
4.2.1 United States VS China: Tuberculosis Vaccine Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tuberculosis Vaccine Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Tuberculosis Vaccine Drug Consumption Comparison
4.3.1 United States VS China: Tuberculosis Vaccine Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Tuberculosis Vaccine Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Tuberculosis Vaccine Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Tuberculosis Vaccine Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023)
4.5 China Based Tuberculosis Vaccine Drug Manufacturers and Market Share
4.5.1 China Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Tuberculosis Vaccine Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023)
4.6 Rest of World Based Tuberculosis Vaccine Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Tuberculosis Vaccine Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immune Vaccine
5.2.2 Therapy Vaccine
5.3 Market Segment by Type
5.3.1 World Tuberculosis Vaccine Drug Production by Type (2018-2029)
5.3.2 World Tuberculosis Vaccine Drug Production Value by Type (2018-2029)
5.3.3 World Tuberculosis Vaccine Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tuberculosis Vaccine Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Self-Procurement
6.2.2 UNICEF
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Tuberculosis Vaccine Drug Production by Application (2018-2029)
6.3.2 World Tuberculosis Vaccine Drug Production Value by Application (2018-2029)
6.3.3 World Tuberculosis Vaccine Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Tuberculosis Vaccine Drug Product and Services
7.1.4 Merck Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Details
7.2.2 Japan BCG Lab Major Business
7.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Product and Services
7.2.4 Japan BCG Lab Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Japan BCG Lab Recent Developments/Updates
7.2.6 Japan BCG Lab Competitive Strengths & Weaknesses
7.3 Serum Institute of India
7.3.1 Serum Institute of India Details
7.3.2 Serum Institute of India Major Business
7.3.3 Serum Institute of India Tuberculosis Vaccine Drug Product and Services
7.3.4 Serum Institute of India Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Serum Institute of India Recent Developments/Updates
7.3.6 Serum Institute of India Competitive Strengths & Weaknesses
7.4 AJ Vaccines
7.4.1 AJ Vaccines Details
7.4.2 AJ Vaccines Major Business
7.4.3 AJ Vaccines Tuberculosis Vaccine Drug Product and Services
7.4.4 AJ Vaccines Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AJ Vaccines Recent Developments/Updates
7.4.6 AJ Vaccines Competitive Strengths & Weaknesses
7.5 BioFarma
7.5.1 BioFarma Details
7.5.2 BioFarma Major Business
7.5.3 BioFarma Tuberculosis Vaccine Drug Product and Services
7.5.4 BioFarma Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 BioFarma Recent Developments/Updates
7.5.6 BioFarma Competitive Strengths & Weaknesses
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Details
7.6.2 GreenSignal Bio Pharma Major Business
7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product and Services
7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 GreenSignal Bio Pharma Recent Developments/Updates
7.6.6 GreenSignal Bio Pharma Competitive Strengths & Weaknesses
7.7 China National Biotec
7.7.1 China National Biotec Details
7.7.2 China National Biotec Major Business
7.7.3 China National Biotec Tuberculosis Vaccine Drug Product and Services
7.7.4 China National Biotec Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 China National Biotec Recent Developments/Updates
7.7.6 China National Biotec Competitive Strengths & Weaknesses
7.8 Biomed Lublin
7.8.1 Biomed Lublin Details
7.8.2 Biomed Lublin Major Business
7.8.3 Biomed Lublin Tuberculosis Vaccine Drug Product and Services
7.8.4 Biomed Lublin Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Biomed Lublin Recent Developments/Updates
7.8.6 Biomed Lublin Competitive Strengths & Weaknesses
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Details
7.9.2 Taj Pharmaceuticals Major Business
7.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product and Services
7.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Taj Pharmaceuticals Recent Developments/Updates
7.9.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Details
7.10.2 Ataulpho de Paiva Major Business
7.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Product and Services
7.10.4 Ataulpho de Paiva Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Ataulpho de Paiva Recent Developments/Updates
7.10.6 Ataulpho de Paiva Competitive Strengths & Weaknesses
7.11 IVAC
7.11.1 IVAC Details
7.11.2 IVAC Major Business
7.11.3 IVAC Tuberculosis Vaccine Drug Product and Services
7.11.4 IVAC Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 IVAC Recent Developments/Updates
7.11.6 IVAC Competitive Strengths & Weaknesses
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Details
7.12.2 Queen Saovabha Mem. Inst Major Business
7.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product and Services
7.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
7.12.6 Queen Saovabha Mem. Inst Competitive Strengths & Weaknesses
7.13 Microgen
7.13.1 Microgen Details
7.13.2 Microgen Major Business
7.13.3 Microgen Tuberculosis Vaccine Drug Product and Services
7.13.4 Microgen Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Microgen Recent Developments/Updates
7.13.6 Microgen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tuberculosis Vaccine Drug Industry Chain
8.2 Tuberculosis Vaccine Drug Upstream Analysis
8.2.1 Tuberculosis Vaccine Drug Core Raw Materials
8.2.2 Main Manufacturers of Tuberculosis Vaccine Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Tuberculosis Vaccine Drug Production Mode
8.6 Tuberculosis Vaccine Drug Procurement Model
8.7 Tuberculosis Vaccine Drug Industry Sales Model and Sales Channels
8.7.1 Tuberculosis Vaccine Drug Sales Model
8.7.2 Tuberculosis Vaccine Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Tuberculosis Vaccine Drug Introduction
1.2 World Tuberculosis Vaccine Drug Supply & Forecast
1.2.1 World Tuberculosis Vaccine Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Tuberculosis Vaccine Drug Production (2018-2029)
1.2.3 World Tuberculosis Vaccine Drug Pricing Trends (2018-2029)
1.3 World Tuberculosis Vaccine Drug Production by Region (Based on Production Site)
1.3.1 World Tuberculosis Vaccine Drug Production Value by Region (2018-2029)
1.3.2 World Tuberculosis Vaccine Drug Production by Region (2018-2029)
1.3.3 World Tuberculosis Vaccine Drug Average Price by Region (2018-2029)
1.3.4 North America Tuberculosis Vaccine Drug Production (2018-2029)
1.3.5 Europe Tuberculosis Vaccine Drug Production (2018-2029)
1.3.6 China Tuberculosis Vaccine Drug Production (2018-2029)
1.3.7 Japan Tuberculosis Vaccine Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tuberculosis Vaccine Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tuberculosis Vaccine Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Tuberculosis Vaccine Drug Demand (2018-2029)
2.2 World Tuberculosis Vaccine Drug Consumption by Region
2.2.1 World Tuberculosis Vaccine Drug Consumption by Region (2018-2023)
2.2.2 World Tuberculosis Vaccine Drug Consumption Forecast by Region (2024-2029)
2.3 United States Tuberculosis Vaccine Drug Consumption (2018-2029)
2.4 China Tuberculosis Vaccine Drug Consumption (2018-2029)
2.5 Europe Tuberculosis Vaccine Drug Consumption (2018-2029)
2.6 Japan Tuberculosis Vaccine Drug Consumption (2018-2029)
2.7 South Korea Tuberculosis Vaccine Drug Consumption (2018-2029)
2.8 ASEAN Tuberculosis Vaccine Drug Consumption (2018-2029)
2.9 India Tuberculosis Vaccine Drug Consumption (2018-2029)
3 WORLD TUBERCULOSIS VACCINE DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Tuberculosis Vaccine Drug Production Value by Manufacturer (2018-2023)
3.2 World Tuberculosis Vaccine Drug Production by Manufacturer (2018-2023)
3.3 World Tuberculosis Vaccine Drug Average Price by Manufacturer (2018-2023)
3.4 Tuberculosis Vaccine Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Tuberculosis Vaccine Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Tuberculosis Vaccine Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Tuberculosis Vaccine Drug in 2022
3.6 Tuberculosis Vaccine Drug Market: Overall Company Footprint Analysis
3.6.1 Tuberculosis Vaccine Drug Market: Region Footprint
3.6.2 Tuberculosis Vaccine Drug Market: Company Product Type Footprint
3.6.3 Tuberculosis Vaccine Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Tuberculosis Vaccine Drug Production Value Comparison
4.1.1 United States VS China: Tuberculosis Vaccine Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Tuberculosis Vaccine Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Tuberculosis Vaccine Drug Production Comparison
4.2.1 United States VS China: Tuberculosis Vaccine Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tuberculosis Vaccine Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Tuberculosis Vaccine Drug Consumption Comparison
4.3.1 United States VS China: Tuberculosis Vaccine Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Tuberculosis Vaccine Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Tuberculosis Vaccine Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Tuberculosis Vaccine Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023)
4.5 China Based Tuberculosis Vaccine Drug Manufacturers and Market Share
4.5.1 China Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Tuberculosis Vaccine Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023)
4.6 Rest of World Based Tuberculosis Vaccine Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Tuberculosis Vaccine Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immune Vaccine
5.2.2 Therapy Vaccine
5.3 Market Segment by Type
5.3.1 World Tuberculosis Vaccine Drug Production by Type (2018-2029)
5.3.2 World Tuberculosis Vaccine Drug Production Value by Type (2018-2029)
5.3.3 World Tuberculosis Vaccine Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tuberculosis Vaccine Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Self-Procurement
6.2.2 UNICEF
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Tuberculosis Vaccine Drug Production by Application (2018-2029)
6.3.2 World Tuberculosis Vaccine Drug Production Value by Application (2018-2029)
6.3.3 World Tuberculosis Vaccine Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Tuberculosis Vaccine Drug Product and Services
7.1.4 Merck Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Details
7.2.2 Japan BCG Lab Major Business
7.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Product and Services
7.2.4 Japan BCG Lab Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Japan BCG Lab Recent Developments/Updates
7.2.6 Japan BCG Lab Competitive Strengths & Weaknesses
7.3 Serum Institute of India
7.3.1 Serum Institute of India Details
7.3.2 Serum Institute of India Major Business
7.3.3 Serum Institute of India Tuberculosis Vaccine Drug Product and Services
7.3.4 Serum Institute of India Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Serum Institute of India Recent Developments/Updates
7.3.6 Serum Institute of India Competitive Strengths & Weaknesses
7.4 AJ Vaccines
7.4.1 AJ Vaccines Details
7.4.2 AJ Vaccines Major Business
7.4.3 AJ Vaccines Tuberculosis Vaccine Drug Product and Services
7.4.4 AJ Vaccines Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AJ Vaccines Recent Developments/Updates
7.4.6 AJ Vaccines Competitive Strengths & Weaknesses
7.5 BioFarma
7.5.1 BioFarma Details
7.5.2 BioFarma Major Business
7.5.3 BioFarma Tuberculosis Vaccine Drug Product and Services
7.5.4 BioFarma Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 BioFarma Recent Developments/Updates
7.5.6 BioFarma Competitive Strengths & Weaknesses
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Details
7.6.2 GreenSignal Bio Pharma Major Business
7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product and Services
7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 GreenSignal Bio Pharma Recent Developments/Updates
7.6.6 GreenSignal Bio Pharma Competitive Strengths & Weaknesses
7.7 China National Biotec
7.7.1 China National Biotec Details
7.7.2 China National Biotec Major Business
7.7.3 China National Biotec Tuberculosis Vaccine Drug Product and Services
7.7.4 China National Biotec Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 China National Biotec Recent Developments/Updates
7.7.6 China National Biotec Competitive Strengths & Weaknesses
7.8 Biomed Lublin
7.8.1 Biomed Lublin Details
7.8.2 Biomed Lublin Major Business
7.8.3 Biomed Lublin Tuberculosis Vaccine Drug Product and Services
7.8.4 Biomed Lublin Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Biomed Lublin Recent Developments/Updates
7.8.6 Biomed Lublin Competitive Strengths & Weaknesses
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Details
7.9.2 Taj Pharmaceuticals Major Business
7.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product and Services
7.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Taj Pharmaceuticals Recent Developments/Updates
7.9.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Details
7.10.2 Ataulpho de Paiva Major Business
7.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Product and Services
7.10.4 Ataulpho de Paiva Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Ataulpho de Paiva Recent Developments/Updates
7.10.6 Ataulpho de Paiva Competitive Strengths & Weaknesses
7.11 IVAC
7.11.1 IVAC Details
7.11.2 IVAC Major Business
7.11.3 IVAC Tuberculosis Vaccine Drug Product and Services
7.11.4 IVAC Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 IVAC Recent Developments/Updates
7.11.6 IVAC Competitive Strengths & Weaknesses
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Details
7.12.2 Queen Saovabha Mem. Inst Major Business
7.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product and Services
7.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
7.12.6 Queen Saovabha Mem. Inst Competitive Strengths & Weaknesses
7.13 Microgen
7.13.1 Microgen Details
7.13.2 Microgen Major Business
7.13.3 Microgen Tuberculosis Vaccine Drug Product and Services
7.13.4 Microgen Tuberculosis Vaccine Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Microgen Recent Developments/Updates
7.13.6 Microgen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tuberculosis Vaccine Drug Industry Chain
8.2 Tuberculosis Vaccine Drug Upstream Analysis
8.2.1 Tuberculosis Vaccine Drug Core Raw Materials
8.2.2 Main Manufacturers of Tuberculosis Vaccine Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Tuberculosis Vaccine Drug Production Mode
8.6 Tuberculosis Vaccine Drug Procurement Model
8.7 Tuberculosis Vaccine Drug Industry Sales Model and Sales Channels
8.7.1 Tuberculosis Vaccine Drug Sales Model
8.7.2 Tuberculosis Vaccine Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Tuberculosis Vaccine Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Tuberculosis Vaccine Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Tuberculosis Vaccine Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Tuberculosis Vaccine Drug Production Value Market Share by Region (2018-2023)
Table 5. World Tuberculosis Vaccine Drug Production Value Market Share by Region (2024-2029)
Table 6. World Tuberculosis Vaccine Drug Production by Region (2018-2023) & (K Units)
Table 7. World Tuberculosis Vaccine Drug Production by Region (2024-2029) & (K Units)
Table 8. World Tuberculosis Vaccine Drug Production Market Share by Region (2018-2023)
Table 9. World Tuberculosis Vaccine Drug Production Market Share by Region (2024-2029)
Table 10. World Tuberculosis Vaccine Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Tuberculosis Vaccine Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Tuberculosis Vaccine Drug Major Market Trends
Table 13. World Tuberculosis Vaccine Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Tuberculosis Vaccine Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Tuberculosis Vaccine Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Tuberculosis Vaccine Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Tuberculosis Vaccine Drug Producers in 2022
Table 18. World Tuberculosis Vaccine Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Tuberculosis Vaccine Drug Producers in 2022
Table 20. World Tuberculosis Vaccine Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Tuberculosis Vaccine Drug Company Evaluation Quadrant
Table 22. World Tuberculosis Vaccine Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Tuberculosis Vaccine Drug Production Site of Key Manufacturer
Table 24. Tuberculosis Vaccine Drug Market: Company Product Type Footprint
Table 25. Tuberculosis Vaccine Drug Market: Company Product Application Footprint
Table 26. Tuberculosis Vaccine Drug Competitive Factors
Table 27. Tuberculosis Vaccine Drug New Entrant and Capacity Expansion Plans
Table 28. Tuberculosis Vaccine Drug Mergers & Acquisitions Activity
Table 29. United States VS China Tuberculosis Vaccine Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Tuberculosis Vaccine Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Tuberculosis Vaccine Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Tuberculosis Vaccine Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Tuberculosis Vaccine Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Tuberculosis Vaccine Drug Production Market Share (2018-2023)
Table 37. China Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Tuberculosis Vaccine Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Tuberculosis Vaccine Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Tuberculosis Vaccine Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production Market Share (2018-2023)
Table 47. World Tuberculosis Vaccine Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Tuberculosis Vaccine Drug Production by Type (2018-2023) & (K Units)
Table 49. World Tuberculosis Vaccine Drug Production by Type (2024-2029) & (K Units)
Table 50. World Tuberculosis Vaccine Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Tuberculosis Vaccine Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Tuberculosis Vaccine Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Tuberculosis Vaccine Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Tuberculosis Vaccine Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Tuberculosis Vaccine Drug Production by Application (2018-2023) & (K Units)
Table 56. World Tuberculosis Vaccine Drug Production by Application (2024-2029) & (K Units)
Table 57. World Tuberculosis Vaccine Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Tuberculosis Vaccine Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Tuberculosis Vaccine Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Tuberculosis Vaccine Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Tuberculosis Vaccine Drug Product and Services
Table 64. Merck Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 68. Japan BCG Lab Major Business
Table 69. Japan BCG Lab Tuberculosis Vaccine Drug Product and Services
Table 70. Japan BCG Lab Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Japan BCG Lab Recent Developments/Updates
Table 72. Japan BCG Lab Competitive Strengths & Weaknesses
Table 73. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 74. Serum Institute of India Major Business
Table 75. Serum Institute of India Tuberculosis Vaccine Drug Product and Services
Table 76. Serum Institute of India Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Serum Institute of India Recent Developments/Updates
Table 78. Serum Institute of India Competitive Strengths & Weaknesses
Table 79. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 80. AJ Vaccines Major Business
Table 81. AJ Vaccines Tuberculosis Vaccine Drug Product and Services
Table 82. AJ Vaccines Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AJ Vaccines Recent Developments/Updates
Table 84. AJ Vaccines Competitive Strengths & Weaknesses
Table 85. BioFarma Basic Information, Manufacturing Base and Competitors
Table 86. BioFarma Major Business
Table 87. BioFarma Tuberculosis Vaccine Drug Product and Services
Table 88. BioFarma Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. BioFarma Recent Developments/Updates
Table 90. BioFarma Competitive Strengths & Weaknesses
Table 91. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors
Table 92. GreenSignal Bio Pharma Major Business
Table 93. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product and Services
Table 94. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. GreenSignal Bio Pharma Recent Developments/Updates
Table 96. GreenSignal Bio Pharma Competitive Strengths & Weaknesses
Table 97. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 98. China National Biotec Major Business
Table 99. China National Biotec Tuberculosis Vaccine Drug Product and Services
Table 100. China National Biotec Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. China National Biotec Recent Developments/Updates
Table 102. China National Biotec Competitive Strengths & Weaknesses
Table 103. Biomed Lublin Basic Information, Manufacturing Base and Competitors
Table 104. Biomed Lublin Major Business
Table 105. Biomed Lublin Tuberculosis Vaccine Drug Product and Services
Table 106. Biomed Lublin Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Biomed Lublin Recent Developments/Updates
Table 108. Biomed Lublin Competitive Strengths & Weaknesses
Table 109. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Taj Pharmaceuticals Major Business
Table 111. Taj Pharmaceuticals Tuberculosis Vaccine Drug Product and Services
Table 112. Taj Pharmaceuticals Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Taj Pharmaceuticals Recent Developments/Updates
Table 114. Taj Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors
Table 116. Ataulpho de Paiva Major Business
Table 117. Ataulpho de Paiva Tuberculosis Vaccine Drug Product and Services
Table 118. Ataulpho de Paiva Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. Ataulpho de Paiva Competitive Strengths & Weaknesses
Table 121. IVAC Basic Information, Manufacturing Base and Competitors
Table 122. IVAC Major Business
Table 123. IVAC Tuberculosis Vaccine Drug Product and Services
Table 124. IVAC Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. IVAC Recent Developments/Updates
Table 126. IVAC Competitive Strengths & Weaknesses
Table 127. Queen Saovabha Mem. Inst Basic Information, Manufacturing Base and Competitors
Table 128. Queen Saovabha Mem. Inst Major Business
Table 129. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product and Services
Table 130. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 132. Microgen Basic Information, Manufacturing Base and Competitors
Table 133. Microgen Major Business
Table 134. Microgen Tuberculosis Vaccine Drug Product and Services
Table 135. Microgen Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Tuberculosis Vaccine Drug Upstream (Raw Materials)
Table 137. Tuberculosis Vaccine Drug Typical Customers
Table 138. Tuberculosis Vaccine Drug Typical Distributors
Table 1. World Tuberculosis Vaccine Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Tuberculosis Vaccine Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Tuberculosis Vaccine Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Tuberculosis Vaccine Drug Production Value Market Share by Region (2018-2023)
Table 5. World Tuberculosis Vaccine Drug Production Value Market Share by Region (2024-2029)
Table 6. World Tuberculosis Vaccine Drug Production by Region (2018-2023) & (K Units)
Table 7. World Tuberculosis Vaccine Drug Production by Region (2024-2029) & (K Units)
Table 8. World Tuberculosis Vaccine Drug Production Market Share by Region (2018-2023)
Table 9. World Tuberculosis Vaccine Drug Production Market Share by Region (2024-2029)
Table 10. World Tuberculosis Vaccine Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Tuberculosis Vaccine Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Tuberculosis Vaccine Drug Major Market Trends
Table 13. World Tuberculosis Vaccine Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Tuberculosis Vaccine Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Tuberculosis Vaccine Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Tuberculosis Vaccine Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Tuberculosis Vaccine Drug Producers in 2022
Table 18. World Tuberculosis Vaccine Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Tuberculosis Vaccine Drug Producers in 2022
Table 20. World Tuberculosis Vaccine Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Tuberculosis Vaccine Drug Company Evaluation Quadrant
Table 22. World Tuberculosis Vaccine Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Tuberculosis Vaccine Drug Production Site of Key Manufacturer
Table 24. Tuberculosis Vaccine Drug Market: Company Product Type Footprint
Table 25. Tuberculosis Vaccine Drug Market: Company Product Application Footprint
Table 26. Tuberculosis Vaccine Drug Competitive Factors
Table 27. Tuberculosis Vaccine Drug New Entrant and Capacity Expansion Plans
Table 28. Tuberculosis Vaccine Drug Mergers & Acquisitions Activity
Table 29. United States VS China Tuberculosis Vaccine Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Tuberculosis Vaccine Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Tuberculosis Vaccine Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Tuberculosis Vaccine Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Tuberculosis Vaccine Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Tuberculosis Vaccine Drug Production Market Share (2018-2023)
Table 37. China Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Tuberculosis Vaccine Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Tuberculosis Vaccine Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Tuberculosis Vaccine Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Tuberculosis Vaccine Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production Market Share (2018-2023)
Table 47. World Tuberculosis Vaccine Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Tuberculosis Vaccine Drug Production by Type (2018-2023) & (K Units)
Table 49. World Tuberculosis Vaccine Drug Production by Type (2024-2029) & (K Units)
Table 50. World Tuberculosis Vaccine Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Tuberculosis Vaccine Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Tuberculosis Vaccine Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Tuberculosis Vaccine Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Tuberculosis Vaccine Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Tuberculosis Vaccine Drug Production by Application (2018-2023) & (K Units)
Table 56. World Tuberculosis Vaccine Drug Production by Application (2024-2029) & (K Units)
Table 57. World Tuberculosis Vaccine Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Tuberculosis Vaccine Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Tuberculosis Vaccine Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Tuberculosis Vaccine Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Tuberculosis Vaccine Drug Product and Services
Table 64. Merck Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 68. Japan BCG Lab Major Business
Table 69. Japan BCG Lab Tuberculosis Vaccine Drug Product and Services
Table 70. Japan BCG Lab Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Japan BCG Lab Recent Developments/Updates
Table 72. Japan BCG Lab Competitive Strengths & Weaknesses
Table 73. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 74. Serum Institute of India Major Business
Table 75. Serum Institute of India Tuberculosis Vaccine Drug Product and Services
Table 76. Serum Institute of India Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Serum Institute of India Recent Developments/Updates
Table 78. Serum Institute of India Competitive Strengths & Weaknesses
Table 79. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 80. AJ Vaccines Major Business
Table 81. AJ Vaccines Tuberculosis Vaccine Drug Product and Services
Table 82. AJ Vaccines Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AJ Vaccines Recent Developments/Updates
Table 84. AJ Vaccines Competitive Strengths & Weaknesses
Table 85. BioFarma Basic Information, Manufacturing Base and Competitors
Table 86. BioFarma Major Business
Table 87. BioFarma Tuberculosis Vaccine Drug Product and Services
Table 88. BioFarma Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. BioFarma Recent Developments/Updates
Table 90. BioFarma Competitive Strengths & Weaknesses
Table 91. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors
Table 92. GreenSignal Bio Pharma Major Business
Table 93. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product and Services
Table 94. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. GreenSignal Bio Pharma Recent Developments/Updates
Table 96. GreenSignal Bio Pharma Competitive Strengths & Weaknesses
Table 97. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 98. China National Biotec Major Business
Table 99. China National Biotec Tuberculosis Vaccine Drug Product and Services
Table 100. China National Biotec Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. China National Biotec Recent Developments/Updates
Table 102. China National Biotec Competitive Strengths & Weaknesses
Table 103. Biomed Lublin Basic Information, Manufacturing Base and Competitors
Table 104. Biomed Lublin Major Business
Table 105. Biomed Lublin Tuberculosis Vaccine Drug Product and Services
Table 106. Biomed Lublin Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Biomed Lublin Recent Developments/Updates
Table 108. Biomed Lublin Competitive Strengths & Weaknesses
Table 109. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Taj Pharmaceuticals Major Business
Table 111. Taj Pharmaceuticals Tuberculosis Vaccine Drug Product and Services
Table 112. Taj Pharmaceuticals Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Taj Pharmaceuticals Recent Developments/Updates
Table 114. Taj Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors
Table 116. Ataulpho de Paiva Major Business
Table 117. Ataulpho de Paiva Tuberculosis Vaccine Drug Product and Services
Table 118. Ataulpho de Paiva Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Ataulpho de Paiva Recent Developments/Updates
Table 120. Ataulpho de Paiva Competitive Strengths & Weaknesses
Table 121. IVAC Basic Information, Manufacturing Base and Competitors
Table 122. IVAC Major Business
Table 123. IVAC Tuberculosis Vaccine Drug Product and Services
Table 124. IVAC Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. IVAC Recent Developments/Updates
Table 126. IVAC Competitive Strengths & Weaknesses
Table 127. Queen Saovabha Mem. Inst Basic Information, Manufacturing Base and Competitors
Table 128. Queen Saovabha Mem. Inst Major Business
Table 129. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product and Services
Table 130. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Queen Saovabha Mem. Inst Recent Developments/Updates
Table 132. Microgen Basic Information, Manufacturing Base and Competitors
Table 133. Microgen Major Business
Table 134. Microgen Tuberculosis Vaccine Drug Product and Services
Table 135. Microgen Tuberculosis Vaccine Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Tuberculosis Vaccine Drug Upstream (Raw Materials)
Table 137. Tuberculosis Vaccine Drug Typical Customers
Table 138. Tuberculosis Vaccine Drug Typical Distributors
LIST OF FIGURES
Figure 1. Tuberculosis Vaccine Drug Picture
Figure 2. World Tuberculosis Vaccine Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tuberculosis Vaccine Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Tuberculosis Vaccine Drug Production (2018-2029) & (K Units)
Figure 5. World Tuberculosis Vaccine Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Tuberculosis Vaccine Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Tuberculosis Vaccine Drug Production Market Share by Region (2018-2029)
Figure 8. North America Tuberculosis Vaccine Drug Production (2018-2029) & (K Units)
Figure 9. Europe Tuberculosis Vaccine Drug Production (2018-2029) & (K Units)
Figure 10. China Tuberculosis Vaccine Drug Production (2018-2029) & (K Units)
Figure 11. Japan Tuberculosis Vaccine Drug Production (2018-2029) & (K Units)
Figure 12. Tuberculosis Vaccine Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 15. World Tuberculosis Vaccine Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 17. China Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 22. India Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Tuberculosis Vaccine Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Tuberculosis Vaccine Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Tuberculosis Vaccine Drug Markets in 2022
Figure 26. United States VS China: Tuberculosis Vaccine Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Tuberculosis Vaccine Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tuberculosis Vaccine Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Tuberculosis Vaccine Drug Production Market Share 2022
Figure 30. China Based Manufacturers Tuberculosis Vaccine Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production Market Share 2022
Figure 32. World Tuberculosis Vaccine Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Tuberculosis Vaccine Drug Production Value Market Share by Type in 2022
Figure 34. Immune Vaccine
Figure 35. Therapy Vaccine
Figure 36. World Tuberculosis Vaccine Drug Production Market Share by Type (2018-2029)
Figure 37. World Tuberculosis Vaccine Drug Production Value Market Share by Type (2018-2029)
Figure 38. World Tuberculosis Vaccine Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Tuberculosis Vaccine Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Tuberculosis Vaccine Drug Production Value Market Share by Application in 2022
Figure 41. Self-Procurement
Figure 42. UNICEF
Figure 43. Other
Figure 44. World Tuberculosis Vaccine Drug Production Market Share by Application (2018-2029)
Figure 45. World Tuberculosis Vaccine Drug Production Value Market Share by Application (2018-2029)
Figure 46. World Tuberculosis Vaccine Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Tuberculosis Vaccine Drug Industry Chain
Figure 48. Tuberculosis Vaccine Drug Procurement Model
Figure 49. Tuberculosis Vaccine Drug Sales Model
Figure 50. Tuberculosis Vaccine Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Tuberculosis Vaccine Drug Picture
Figure 2. World Tuberculosis Vaccine Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tuberculosis Vaccine Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Tuberculosis Vaccine Drug Production (2018-2029) & (K Units)
Figure 5. World Tuberculosis Vaccine Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Tuberculosis Vaccine Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Tuberculosis Vaccine Drug Production Market Share by Region (2018-2029)
Figure 8. North America Tuberculosis Vaccine Drug Production (2018-2029) & (K Units)
Figure 9. Europe Tuberculosis Vaccine Drug Production (2018-2029) & (K Units)
Figure 10. China Tuberculosis Vaccine Drug Production (2018-2029) & (K Units)
Figure 11. Japan Tuberculosis Vaccine Drug Production (2018-2029) & (K Units)
Figure 12. Tuberculosis Vaccine Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 15. World Tuberculosis Vaccine Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 17. China Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 22. India Tuberculosis Vaccine Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Tuberculosis Vaccine Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Tuberculosis Vaccine Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Tuberculosis Vaccine Drug Markets in 2022
Figure 26. United States VS China: Tuberculosis Vaccine Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Tuberculosis Vaccine Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tuberculosis Vaccine Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Tuberculosis Vaccine Drug Production Market Share 2022
Figure 30. China Based Manufacturers Tuberculosis Vaccine Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Tuberculosis Vaccine Drug Production Market Share 2022
Figure 32. World Tuberculosis Vaccine Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Tuberculosis Vaccine Drug Production Value Market Share by Type in 2022
Figure 34. Immune Vaccine
Figure 35. Therapy Vaccine
Figure 36. World Tuberculosis Vaccine Drug Production Market Share by Type (2018-2029)
Figure 37. World Tuberculosis Vaccine Drug Production Value Market Share by Type (2018-2029)
Figure 38. World Tuberculosis Vaccine Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Tuberculosis Vaccine Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Tuberculosis Vaccine Drug Production Value Market Share by Application in 2022
Figure 41. Self-Procurement
Figure 42. UNICEF
Figure 43. Other
Figure 44. World Tuberculosis Vaccine Drug Production Market Share by Application (2018-2029)
Figure 45. World Tuberculosis Vaccine Drug Production Value Market Share by Application (2018-2029)
Figure 46. World Tuberculosis Vaccine Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Tuberculosis Vaccine Drug Industry Chain
Figure 48. Tuberculosis Vaccine Drug Procurement Model
Figure 49. Tuberculosis Vaccine Drug Sales Model
Figure 50. Tuberculosis Vaccine Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
